Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) High-flow nasal cannulas in COVID-19 pneumonia
Journal Information
Vol. 159. Issue 8.
Pages e53 (October 2022)
Vol. 159. Issue 8.
Pages e53 (October 2022)
Letter to the Editor
Full text access
High-flow nasal cannulas in COVID-19 pneumonia
Cánulas nasales de alto flujo en la neumonía por COVID-19
Visits
4
Alejandro González-Castroa,
Corresponding author
e409@humv.es

Corresponding author.
, Aurio Fajardo Campoverdeb, Angello Roncallic
a Servicio de Medicina Intensiva, Hospital Universitario Marqués de Valdecilla, Santander. Spain
b Unidad de Paciente Critico, Hospital Clínico Viña del Mar, Viña del Mar, Chile
c Unidad de Fisioterapia Respiratoria, General Hospital of the State of Alagoas, Maceió, Brazil
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text
Dear Editor:

After reading with special interest García-Pereña et al.’s article,1 available online in your journal, we would like to share some reflections and comments.

The authors assume in their paper that non-intubated patients presenting with an SpO2/FiO2 ratio ≤100 have a severe acute respiratory distress syndrome (ARDS). It is important to point out that unless these patients were breathing ambient aire, FiO2 ranges can vary by more than 10% depending on the device used (nasal tubes, Ventimask or Multi-vent mask).2 Along these lines, based on Todd et al.’s work,3 the relationship between SpO2/FiO2 and PaO2/FiO2 is known to be described based on the following equation: SpO2/FiO2=64+0.84×(PaO2/FiO2) (p<0.0001; r=0.89). Threshold SpO2/FiO2 ratio values of 235 and 315 yielded a sensitivity of 85% with a specificity of 85% and a sensitivity of 91% with a specificity of 56%, respectively, for PaO2/FiO2 ratios of 200 and 300.

Although the current Berlin definition might be deficient for reaching a diagnosis of ARDS, some authors believe that the development and application of standards to define disease processes improves the quality of medical care. Failure to do so could lead to interpretation errors that could have ominous implications for clinical practice.

In fact, an imprudent (time-dependent) use of non-invasive support systems may result in delayed endotracheal intubation and a worse clinical outcome. The presence of a pulmonary lesion causes the distribution of inspiratory forces through the lung tissue to be heterogeneous. An intense inspiratory effort interacts with the solid behavior of the injured lung, thus generating a vertical gradient in the regional transpulmonary pressure. This occurs mainly at the onset of inspiration and may shift pulmonary gas from the non-dependent, anterior lung regions to the dependent posterior regions, a phenomenon known as Pendelluft that causes additional regional overstretching in the dependent lung regions. Finally, it causes an increase in transmural pulmonary capillary pressure and facilitates transvascular fluid leakage, which further aggravates the interstitial and alveolar edema. These mechanisms might lead to spontaneous breathing resulting in a patient self-inflicted lung injury (P-SILI).4

Secondly, in addition to their failure to describe the statistical analysis carried out, we found a lack of variables of great interest in these patients in the comparative section. For example, based on the work published by Liu et al., we believe that variables such as the age, number of comorbidities, ROX index, Glasgow Coma Scale Score, and use of vasopressors on the first day of the high-flow nasal cannula (HFNC) therapy, all of which are independent risk factors for HFNC therapy failure in a multivariate regression,5 cannot be ignored in this type of study.

Finally, we would like to emphasize that another plausible interpretation, considering the data presented by García-Pereña et al.,1 is the fact that delayed intubation in these patients increases mortality in this cohort, with the likelihood of this statement being false being only 6.1% (p=0.0061).

References
[1]
L. García-Pereña, V. Ramos Sesma, M.L. Tornero Divieso, A. Lluna Carrascosa, S. Velasco Fuentes, J. Parra-Ruiz.
Benefits of early use of high-flow-nasal-cannula (HFNC) in patients with COVID-19 associated pneumonia.
[2]
M. Tobin.
Basing respiratory management of COVID-19 on physiological principles.
Am J Respir Crit Care Med, 11 (2020), pp. 1319-1320
[3]
T.W. Rice, A.P. Wheeler, G.R. Bernard, D.L. Hayden, D.A. Schoenfeld, L.B. Ware.
National Institutes of Health, National Heart, Lung, and Blood Institute ARDS Network. Comparison of the SpO2/FiO2 ratio and the PaO2/FiO2 ratio in patients with acute lung injury or ARDS.
Chest, 132 (2007), pp. 410-417
[4]
D.L. Grieco, S.M. Maggiore, O. Roca, E. Spinelli, B.K. Patel, A.W. Thille, et al.
Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS.
Intensive Care Med, 47 (2021), pp. 851-866
[5]
L. Liu, J. Xie, W. Wu, H. Chen, S. Li, H. He, et al.
A simple nomogram for predicting failure of non-invasive respiratory strategies in adults with COVID-19: a retrospective multicentre study.
Lancet Digit Health, 3 (2021), pp. e166-e174
Copyright © 2021. Elsevier España, S.L.U.. All rights reserved
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos